We are live on ! Find out more
BBH icon

VanEck Biotech ETF

83 hedge funds and large institutions have $73M invested in VanEck Biotech ETF in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 14 increasing their positions, 23 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more capital invested

Capital invested by funds: $67.3M → $73M (+$5.69M)

4.56% more ownership

Funds ownership: 18.22%22.78% (+4.6%)

7% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 14

5% less funds holding

Funds holding: 8783 (-4)

39% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 23

70% less call options, than puts

Call options by funds: $257K | Put options by funds: $845K

Holders
83
Holders Change
-4
Holders Change %
-4.6%
% of All Funds
1.83%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
14
Reduced
23
Closed
14
Calls
$257K
Puts
$845K
Net Calls
-$588K
Net Calls Change
-$1.64M
Name Holding Trade Value Shares
Change
Change in
Stake
Wells Fargo
26
Wells Fargo
California
$635K -$110K -813 -14%
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
$602K -$2.1M -15,596 -77%
RJFSA
28
Raymond James Financial Services Advisors
Florida
$544K +$44.6K +331 +8%
FNBOSM
29
First National Bank of South Miami
Florida
$534K -$7.95K -59 -1%
CM
30
Columbus Macro
Pennsylvania
$523K +$550K +4,084 New
TC
31
Telemus Capital
Michigan
$492K -$204K -1,511 -33%
IAMOG
32
Investors Asset Management of Georgia
Georgia
$474K
SC
33
Scotia Capital
Ontario, Canada
$468K -$236K -1,750 -32%
WJWM
34
Williams Jones Wealth Management
New York
$449K
Truist Financial
35
Truist Financial
North Carolina
$439K
PAG
36
Private Advisor Group
New Jersey
$410K
Bank of New York Mellon
37
Bank of New York Mellon
New York
$386K -$426K -3,166 -51%
PAG
38
Pinnacle Advisory Group
Maryland
$325K +$83.9K +623 +33%
Ameriprise
39
Ameriprise
Minnesota
$253K -$213K -1,584 -44%
CIBC World Market
40
CIBC World Market
Ontario, Canada
$235K +$247K +1,833 New
MWA
41
MFA Wealth Advisors
Pennsylvania
$230K
FFN
42
Focus Financial Network
Minnesota
$225K -$64K -475 -21%
TCM
43
Tufton Capital Management
Maryland
$211K
CG
44
Caprock Group
Idaho
$209K +$220K +1,630 New
B
45
Bailard
California
$208K
IAA
46
Ironsides Asset Advisors
North Carolina
$207K -$257K -1,910 -54%
Cambridge Investment Research Advisors
47
Cambridge Investment Research Advisors
Iowa
$201K +$211K +1,569 New
Osaic Holdings
48
Osaic Holdings
Arizona
$198K +$279K +2,068 New
FANJ
49
Financial Architects (New Jersey)
New Jersey
$163K
Citigroup
50
Citigroup
New York
$94K

BBH Hedge Fund Activity: Q1 2020 in Review

83 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q1 2020, worth a combined $73M — up 8.5% from $67.3M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of BBH and 13 opened new positions — a net loss of 1 holder — while 23 trimmed existing stakes and 14 added.

The largest buyer was Goldman Sachs, opening a new position worth an estimated $6.73M. The largest seller was Jane Street, exiting entirely with an estimated $2.81M sold.

  • 83 institutional investors held VanEck Biotech ETF (BBH) as of Q1 2020, down from 87 in Q4 2019.
  • Funds reported $73M of VanEck Biotech ETF stock for Q1 2020, up 8.5% quarter-over-quarter.
  • 13 funds opened new VanEck Biotech ETF positions in Q1 2020 and 14 closed out, a net change of -1 holder.
  • The largest VanEck Biotech ETF buyer in Q1 2020 was Goldman Sachs, an estimated $6.73M added.
  • The largest VanEck Biotech ETF seller in Q1 2020 was Jane Street, an estimated $2.81M sold.

Based on aggregated 13F filings for Q1 2020.